13. Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details

Clinical trials : 3,340 / Drugs : 2,163 - (DrugBank : 383) / Drug target genes : 241 - Drug target pathways : 238

27 trials found

diseases per page:

Showing 1 to 10 of 27 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2015-000922-12-DE (EUCTR)	12/02/2016	02/10/2015	A clinical study to assess medication satisfaction in patients with Relapsing Remitting Multiple Scl ...	A Multinational, Multicenter, Randomized, Parallel Group, Open-Label Study to Assess Medication Sati ...	Relapsing-Remitting Multiple Sclerosis (RRMS) MedDRA version: 19.0;Level: PT;Classification code 100 ...	Trade Name: Copaxone 20 mg/ml INN or Proposed INN: Not applicable Other descriptive name: GLATIRAMER ACE ...	Teva Pharmaceutical Industries, Ltd	NULL	Not Recruiting			Female: yes Male: yes	840	Phase 4	United States;Finland;Spain;Ireland;Turkey;Austria;Israel;Russian Federation;Italy;France;Mexico;Arg ...
2	EUCTR2015-000922-12-FR (EUCTR)	28/01/2016	26/02/2016	A clinical study to assess medication satisfaction in patients with Relapsing Remitting Multiple Scl ...	A Multinational, Multicenter, Randomized, Parallel Group, Open-Label Study to Assess Medication Sati ...	Relapsing-Remitting Multiple Sclerosis (RRMS) MedDRA version: 18.1;Level: PT;Classification code 100 ...	Trade Name: Copaxone 20 mg/ml INN or Proposed INN: Not applicable Other descriptive name: GLATIRAMER ACE ...	Teva Pharmaceutical Industries, Ltd	NULL	Not Recruiting			Female: yes Male: yes	840	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Finland;Spain;Ireland;Turkey;Austria;Russian Federation;Italy;France;Mexico;Argentina; ...
3	EUCTR2015-000922-12-ES (EUCTR)	12/01/2016	13/01/2016	A clinical study to assess medication satisfaction in patients with Relapsing Remitting Multiple Scl ...	A Multinational, Multicenter, Randomized, Parallel Group, Open-Label Study to Assess Medication Sati ...	Relapsing-Remitting Multiple Sclerosis (RRMS) MedDRA version: 18.1;Level: PT;Classification code 100 ...	Trade Name: Copaxone 20 mg/ml INN or Proposed INN: GLATIRAMER ACETATE Other descriptive name: GLATIRAMER ...	Teva Pharmaceutical Industries, Ltd	NULL	Not Recruiting			Female: yes Male: yes	820	Phase 4	United States;Finland;Spain;Ireland;Turkey;Austria;Russian Federation;Italy;France;Mexico;Argentina; ...
4	EUCTR2015-000922-12-PL (EUCTR)	05/01/2016	03/12/2015	A clinical study to assess medication satisfaction in patients with Relapsing Remitting Multiple Scl ...	A Multinational, Multicenter, Randomized, Parallel Group, Open-Label Study to Assess Medication Sati ...	Relapsing-Remitting Multiple Sclerosis (RRMS) MedDRA version: 18.1;Level: PT;Classification code 100 ...	Trade Name: Copaxone 20 mg/ml INN or Proposed INN: Not applicable Other descriptive name: GLATIRAMER ACE ...	Teva Pharmaceutical Industries, Ltd	NULL	Not Recruiting			Female: yes Male: yes	840	Phase 4	United States;Finland;Spain;Ireland;Turkey;Austria;Israel;Russian Federation;Italy;France;Mexico;Arg ...
5	EUCTR2015-000922-12-BE (EUCTR)	04/01/2016	01/10/2015	A clinical study to assess medication satisfaction in patients with Relapsing Remitting Multiple Scl ...	A Multinational, Multicenter, Randomized, Parallel Group, Open-Label Study to Assess Medication Sati ...	Relapsing-Remitting Multiple Sclerosis (RRMS) MedDRA version: 18.1;Level: PT;Classification code 100 ...	Trade Name: Copaxone 20 mg/ml INN or Proposed INN: Not applicable Other descriptive name: GLATIRAMER ACE ...	Teva Pharmaceutical Industries, Ltd	NULL	Not Recruiting			Female: yes Male: yes	840	Phase 4	United States;Finland;Spain;Ireland;Turkey;Austria;Israel;Russian Federation;Italy;France;Mexico;Arg ...
6	EUCTR2015-000922-12-IE (EUCTR)	22/12/2015	09/10/2015	A clinical study to assess medication satisfaction in patients with Relapsing Remitting Multiple Scl ...	A Multinational, Multicenter, Randomized, Parallel Group, Open-Label Study to Assess Medication Sati ...	Relapsing-Remitting Multiple Sclerosis (RRMS) MedDRA version: 19.0;Level: PT;Classification code 100 ...	Trade Name: Copaxone 20 mg/ml INN or Proposed INN: Not applicable Other descriptive name: GLATIRAMER ACE ...	Teva Pharmaceutical Industries, Ltd	NULL	Not Recruiting			Female: yes Male: yes	840	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Finland;Spain;Ireland;Turkey;Austria;Israel;Russian Federation;Italy;France;Mexico;Arg ...
7	EUCTR2015-000922-12-FI (EUCTR)	15/12/2015	07/12/2015	A clinical study to assess medication satisfaction in patients with Relapsing Remitting Multiple Scl ...	A Multinational, Multicenter, Randomized, Parallel Group, Open-Label Study to Assess Medication Sati ...	Relapsing-Remitting Multiple Sclerosis (RRMS) MedDRA version: 19.0;Level: PT;Classification code 100 ...	Trade Name: Copaxone 20 mg/ml INN or Proposed INN: Not applicable Other descriptive name: GLATIRAMER ACE ...	Teva Pharmaceutical Industries, Ltd	NULL	Not Recruiting			Female: yes Male: yes	840	Phase 4	United States;Finland;Spain;Ireland;Turkey;Austria;Israel;Russian Federation;Italy;France;Mexico;Arg ...
8	EUCTR2015-000922-12-HR (EUCTR)	11/12/2015	04/02/2016	A clinical study to assess medication satisfaction in patients with Relapsing Remitting Multiple Scl ...	A Multinational, Multicenter, Randomized, Parallel Group, Open-Label Study to Assess Medication Sati ...	Relapsing-Remitting Multiple Sclerosis (RRMS) MedDRA version: 18.1;Level: PT;Classification code 100 ...	Trade Name: Copaxone 20 mg/ml INN or Proposed INN: Not applicable Other descriptive name: GLATIRAMER ACE ...	Teva Pharmaceutical Industries, Ltd	NULL	Not Recruiting			Female: yes Male: yes	840	Phase 4	United States;Finland;Spain;Ireland;Turkey;Austria;Israel;Russian Federation;Italy;France;Mexico;Arg ...
9	EUCTR2015-000922-12-AT (EUCTR)	19/11/2015	01/10/2015	A clinical study to assess medication satisfaction in patients with Relapsing Remitting Multiple Scl ...	A Multinational, Multicenter, Randomized, Parallel Group, Open-Label Study to Assess Medication Sati ...	Relapsing-Remitting Multiple Sclerosis (RRMS) MedDRA version: 19.0;Level: PT;Classification code 100 ...	Trade Name: Copaxone 20 mg/ml INN or Proposed INN: Not applicable Other descriptive name: GLATIRAMER ACE ...	Teva Pharmaceutical Industries, Ltd	NULL	Not Recruiting			Female: yes Male: yes	840	Phase 4	United States;Finland;Spain;Ireland;Turkey;Austria;Israel;Russian Federation;Italy;France;Mexico;Arg ...
10	NCT02499900 (ClinicalTrials.gov)	August 10, 2015	1/7/2015	CONFIDENCE: A Multinational, Multicenter, Randomized, Parallel Group, Open-Label Study to Assess Med ...	CONFIDENCE: A Multinational, Multicenter, Randomized, Parallel Group, Open-Label Study to Assess Med ...	Multiple Sclerosis	Drug: Copaxone ®	Teva Branded Pharmaceutical Products R&D, Inc.	NULL	Completed	18 Years	N/A	All	861	Phase 4	United States;Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;P ...

First Previous1 2 3Next Last